Publisher Correction: The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)

Leukemia. 2021 Oct;35(10):3038. doi: 10.1038/s41375-021-01412-0.
No abstract available

Publication types

  • Published Erratum